Uniqure

Yahoo Finance • 5 hours ago

Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against uniQure N.V. (NASDAQ: QURE) and certain of its... Full story

Yahoo Finance • 19 hours ago

uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE

NEW ORLEANS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against un... Full story

Yahoo Finance • 2 days ago

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until Ap... Full story

Yahoo Finance • 6 days ago

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violation... Full story

Yahoo Finance • 6 days ago

uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline

Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? Affected uniQure N.V.Investor Summary Who: uniQure N.V. (NASDAQ: QURE)What: Securities fraud class action lawsuit filedClass Period: September 24, 2025, a... Full story

Yahoo Finance • 7 days ago

QURE SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of uniQure N.V. Investors - Contact Kirby McInerney LLP by April 13, 2026

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased uniQure N.V. (“uniQure” or the “Company”) (NASDAQ:QURE) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigatio... Full story

Yahoo Finance • 9 days ago

Holzer & Holzer, LLC Reminds QURE Investors of the April 13, 2026 Lead Plaintiff Deadline in the uniQure N.V. Securities Class Action

ATLANTA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE). The lawsuit alleges that Defendants issued false and misleading statements and... Full story

Yahoo Finance • 10 days ago

QURE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the uniQure N.V. Class Action

SAN DIEGO, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24,... Full story

Yahoo Finance • 10 days ago

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

NEW YORK, Feb. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025, a... Full story

Yahoo Finance • 10 days ago

What Makes BioMarin (BMRN) so Attractive

BioMarin Pharmaceutical (NASDAQ:BMRN) is one of the 17 biotechnology stocks with more than 50% upside. As of February 12 closing, BioMarin Pharmaceutical (NASDAQ:BMRN) carried a moderately bullish analyst sentiment. Of the 15 analysts cov... Full story

Yahoo Finance • 13 days ago

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025, a... Full story

Yahoo Finance • 19 days ago

Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. on R. Dennis’s Substack’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.'s share was trading at $106.90 as of January 28th. MRK’s tra... Full story

Yahoo Finance • 20 days ago

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

~ Supraphysiological expression of α-Gal A activity maintained for over a year in longest treated patient as of data cutoff date ~ ~ Stable Lyso-Gb3 levels maintained post-dosing, regardless of enzyme replacement therapy status across all... Full story

Yahoo Finance • 24 days ago

uniQure (QURE) Navigates Gene Therapy Development as Investors Weigh Long-Term Potential

Apis Capital Advisors’ Apis Flagship Fund released its Q4 2025 investor letter. A copy of the letter can be downloaded here. Apis Flagship Fund delivered strong performance in the fourth quarter of 2025, with the Fund up 10.0% net for the... Full story

Yahoo Finance • 2 months ago

What Do Analysts Think About UniQure (QURE)?

UniQure (NASDAQ:QURE) is one of the best small cap stocks to buy with huge upside potential. Stifel slashed the price target on UniQure (NASDAQ:QURE) to $40 from $50 on December 11, keeping a Buy rating on the stock and stating that it “re... Full story

Yahoo Finance • 2 months ago

QURE INVESTIGATION: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

RADNOR, Pa., Dec. 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDA... Full story

Yahoo Finance • 3 months ago

Notice of Investigation of QURE: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

RADNOR, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDA... Full story

Yahoo Finance • 3 months ago

7 Hidden Multibagger Stocks to Invest In

In this article, we will take a look at the top 7 hidden multibagger stocks to invest in. Multibaggers often take the limelight because of their stellar returns, but it isn’t always easy to catch these multibaggers while they are in the p... Full story

Yahoo Finance • 3 months ago

Here’s What Boosted ClearPoint Neuro (CLPT) in Q3

Deep Sail Capital, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here. The fund returned 5.8% net of fees in the third quarter, outperforming the Russell 2000 Mid Cap G... Full story

Yahoo Finance • 3 months ago

uniQure N.V. (QURE): A Bear Case Theory

We came across a bearish thesis on uniQure N.V. on augur’s substack. In this article, we will summarize the bulls’ thesis on QURE. uniQure N.V.'s share was trading at $27.51 as of November 28th. QURE’s forward P/E was 27.93 according to Ya... Full story